Effects of sedation during upper gastrointestinal endoscopy on endocrine response and cardiorespiratory function

Abstract

Upper gastrointestinal endoscopy is often accompanied by tachycardia which is known to be an important pathogenic factor in the development of myocardial ischemia. The pathogenesis of tachycardia is unknown but the condition is thought to be due to the endocrine response to endoscopy. The purpose of the present study was to investigate the effects of sedation on the endocrine response and cardiorespiratory function. Forty patients scheduled for diagnostic upper gastrointestinal endoscopy were randomized into 2 groups. While the patients in the first group did not receive sedation during upper gastrointestinal endoscopy, the patients in the second group were sedated with intravenous midazolam at the dose of 5 mg for those under 65 years or 2.5 mg for those aged 65 years or more. Midazolam was administered by slow infusion. In both groups, blood pressure, ECG tracing, heart rate, and peripheral oxygen saturation (SpO 2 ) were monitored during endoscopy. In addition, blood samples for the determination of cortisol, glucose and C-reactive protein levels were obtained from patients in both groups prior to and following endoscopy. Heart rate and systolic arterial pressure changes were within normal limits in both groups. Comparison of the two groups regarding the values of these two parameters did not reveal a significant difference, while a statistically significant reduction in SpO 2 was found in the sedation group. No significant differences in serum cortisol, glucose or C-reactive protein levels were observed between the sedated and non-sedated group. Sedation with midazolam did not reduce the endocrine response and the tachycardia developing during upper gastrointestinal endoscopy, but increased the reduction in SpO 2 .

Preoperative stress and anxiety in day-care patients and inpatients undergoing fast-track surgery

“…Midazolam might have attenuated the endocrine response in some of them. 16 In our study, we detected lack of relation between findings in bio-feedback and patients' perception. In addition, VAS¼0 in 22 patients in all four assessments might indicate that some patients were reluctant to indicate their current level of anxiety and fear before operation.…”

Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study

“…Anesthesia can delay patient recovery and discharge time, and increases the risk of cardiopulmonary complications, which are understood to account for ~50% mortality and ~60% morbidity associated with upper gastrointestinal endoscopy (5,6). This risk is increased in elderly patients or those with cardiovascular diseases and upper gastrointestinal bleeding (7). Arterial hypoxemia, arrhythmias and myocardial ischemia have been reported following gastroscopy with anesthesia (7).…”

“…This risk is increased in elderly patients or those with cardiovascular diseases and upper gastrointestinal bleeding (7). Arterial hypoxemia, arrhythmias and myocardial ischemia have been reported following gastroscopy with anesthesia (7).…”

Effects of remifentanil on awakening of propofol sedated patients submitted to upper gastrointestinal endoscopy: a randomized clinical trial

“…Upper GI endoscopy is often accompanied by tachycardia, suggesting the occurrence of an endocrine response to the stress caused by the exam. 22 …”